Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Navigating Life and Loss in Pediatric Multiple Sclerosis.
Modifiable Comorbidities and Disability in Multiple Sclerosis.
Fingolimod (Gilenya) licence extended
Effects of non-steroidal antiinflammatory drugs on D-serine-induced oxidative stress in vitro.
Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis.
Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.
Soluble adenylyl cyclase is necessary and sufficient to overcome the block of axonal growth by myelin-associated factors.
Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
Resveratrol effects on astrocyte function: Relevance to neurodegenerative diseases.
Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.
Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis - Association and Prediction.
Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study.
Erythrocyte membrane Fatty acids in multiple sclerosis patients and hot-nature dietary intervention with co-supplemented hemp-seed and evening-primrose oils.
Pre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient.
25-Hydroxycholecalciferol status in plasma is linearly correlated to daily summer pasture time in cattle at 56°N.
Upregulation of integrin expression on monocytes in multiple sclerosis patients treated with natalizumab.
Effects of multidisciplinary rehabilitation on chronic fatigue in multiple sclerosis: a randomized controlled trial.
Molecular cloning of a human cannabinoid receptor which is also expressed in testis.
Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
Natalizumab-associated progressive multifocal leukoencephalopathy in a patient with multiple sclerosis: a postmortem study.
Transfer of Natalizumab into Breast Milk in a Mother with Multiple Sclerosis.
Systematic localization of common disease-associated variation in regulatory DNA.
Therapy-related acute leukemia in two patients with multiple sclerosis treated with Mitoxantrone.
A Genome-Wide Integrative Genomic Study Localizes Genetic Factors Influencing Antibodies against Epstein-Barr Virus Nuclear Antigen 1 (EBNA-1).
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.

Pages